These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 4094123)
41. Letter: Local immunity and ulcerative colitis. Baklien K; Brandtzaeg P Lancet; 1974 Aug; 2(7877):411-2. PubMed ID: 4136940 [No Abstract] [Full Text] [Related]
42. Serum lysozyme in inflammatory bowel disease. Nugent FW; Mallari R; George H; Ridley N Gastroenterology; 1976 Jun; 70(6):1014-6. PubMed ID: 1269861 [TBL] [Abstract][Full Text] [Related]
43. [Change in some blood serum carbohydrate-protein complexes in nonspecific ulcerative colitis]. Konsistorum AV Klin Med (Mosk); 1971 Jan; 49(1):106-10. PubMed ID: 5576384 [No Abstract] [Full Text] [Related]
44. Mean platelet volume as a possible marker for monitoring the disease activity in ulcerative colitis. Bai M; Xing L; Feng J; Huang L; Li J; Liang G Int J Lab Hematol; 2016 Aug; 38(4):e77-9. PubMed ID: 27174809 [No Abstract] [Full Text] [Related]
49. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis. Malham M; Carlsen K; Riis L; Paerregaard A; Vind I; Fenger M; Wewer V Scand J Gastroenterol; 2019 Oct; 54(10):1214-1219. PubMed ID: 31526273 [No Abstract] [Full Text] [Related]
50. Plasma viscosity: a potential predictor of both medical treatment response and clinical stage of ulcerative colitis. Yakar T; Cosar AM; Gokturk HS; Kanat UG; Parlakgumus A; Kozanoglu I; Serin E Ann Ital Chir; 2016; 87():531-543. PubMed ID: 28070034 [TBL] [Abstract][Full Text] [Related]
51. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis]. Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267 [TBL] [Abstract][Full Text] [Related]
52. [Application of chosen granulocyte markers in diagnostics of Leśniowski-Crohn's disease and ulcerative colitis--preliminary research]. Fedak D; Pawlica D; Ciećko-Michalska I; Solnica B; Mach T Przegl Lek; 2010; 67(2):114-8. PubMed ID: 20557011 [TBL] [Abstract][Full Text] [Related]
53. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Niederau C; Backmerhoff F; Schumacher B; Niederau C Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126 [TBL] [Abstract][Full Text] [Related]
54. [Value of platelet count as an activity index in chronic inflammatory intestinal diseases]. Olm Font M; Guevara C; García-Pugés A; Navarro S Med Clin (Barc); 1988 Oct; 91(10):397. PubMed ID: 3216739 [No Abstract] [Full Text] [Related]
55. Assessment of disease activity in ulcerative colitis using indium-111-labelled leukocyte faecal excretion. Saverymuttu SH; Peters AM; Hodgson HJ; Chadwick VS Scand J Gastroenterol; 1983 Oct; 18(7):907-12. PubMed ID: 6676924 [TBL] [Abstract][Full Text] [Related]
56. Prognostic value of rectal biopsies in idiopathic ulcerative colitis. Vadera V; Vora IM; Candes FP; Plumber ST; Naik SR Indian J Gastroenterol; 1989 Oct; 8(4):241-3. PubMed ID: 2599563 [TBL] [Abstract][Full Text] [Related]
57. [Hepatic changes in patients with nonspecific ulcerative colitis]. Pontes RM; Muarrek FJ; Strauss E; Guembarowski AM Arq Gastroenterol; 1995; 32(2):48-53. PubMed ID: 8540801 [TBL] [Abstract][Full Text] [Related]
58. Elevated serum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis. Boehme MW; Autschbach F; Zuna I; Scherbaum WA; Stange E; Raeth U; Sieg A; Stremmel W Gastroenterology; 1997 Jul; 113(1):107-17. PubMed ID: 9207268 [TBL] [Abstract][Full Text] [Related]
59. Transcobalamin II level in peripheral blood monocytes--a biochemical marker in inflammatory diseases of the bowel. Rachmilewitz D; Ligumsky M; Rachmilewitz B; Rachmilewitz M; Tarcic N; Schlesinger M Gastroenterology; 1980 Jan; 78(1):43-6. PubMed ID: 7350034 [No Abstract] [Full Text] [Related]
60. [Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data]. Ferraro PM; D'Ovidio V; Bresci G; Astegiano M; Principi B; D'Inca' R; Testa R; Valpiani D; Guidi L; Armuzzi A; Costa F; Aratari A; Vecchi M; De Franchis R; Di Leo V; Ricci C; Riegler G; Colombo E; Repaci G; Lecis P; Silla M; Passalacqua S G Ital Nefrol; 2012; 29 Suppl 54():S144-6. PubMed ID: 22388848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]